Cannabinoids, Medical Cannabis, Neurodiversity, and Autism
Joshua Weinstein M.B.A., Ph.D.
Founder and CEO I Care 4 Autism and Shema Kolainu - Hear our voices
On December 17th, 2019, The International Center for Autism Research (ICare4Autism) hosted the annual conference at the Albert Einstein College of Medicine and Montefiore Medical Center. With numerous international and local distinguished speakers, this year’s conference, titled: Cannabinoids, Medical Cannabis, Neurodiversity, and Autism focused on the potential benefits of the cannabis extract cannabidiol or CBD, as a treatment for autism.
ICare4Autism President and Founder Dr. Joshua Weinstein and ICare4Autism Advisory Committee Chairman Dr. Eric Hollander started the day with a warm welcome to all attendees, and a heartfelt thank you to event sponsors.“Hope is a key ingredient in advancing our cause,” Dr. Weinstein said. “We should never give up the hope of creating a world with more opportunities for those with autism.”
Jonathan Alpert M.D; Ph.D.
Dorothy and marty silverman chair in Psychiatry. Chair, Department of Psychiatry and Behavioral Sciences
Dr. Jonathan Alpert, Chairman of the Department of Psychiatry and Behavioral Sciences at the Albert Einstein College of Medicine, provided a welcome from the college.
​
Presentations began with Dr. Eric Hollander, in a lecture titled ‘Novel Therapeutics with Cannabidavarin (CBDB) and Oxytocin/Vasopressin in Autism Spectrum Disorder’.
​
Following Dr. Hollander was a stimulating presentation delivered by Dr. Michael Dor, titled: Cannabis Treat of Autistic Children in Israel and Process of Approval of Treatments.
Additional speakers included Dr. Sophie Molholm, Dr. Stephen Shore, Ms. Casara Jean Ferretti, Dr. Chinazo Cunningham, and Ms. Maia Szalavitz.
Eric Hollander, M.D
Director of Autism and Obsessive Compulsive Spectrum Program. Professor of Psychiatry and Behavioral Sciences.
​
Dr. Joshua Weinstein closed the day with final remarks regarding a bright look at the future of cannabis and autism, noting the many potential benefits of the cannabis extract cannabidiol or CBD, as a treatment for autism.
“Today was a great start,” Dr. Weinstein said, “ICare4Autism will continue the initiative to further research, build relations, and spread the word about the healing potential of cannabis.
Michael Dor, M.D, M.P.A
Senior medical advisor of the medical cannabis unit in the Israeli Ministry of Health
Sophie Molhom, Ph. D
Prof. Departments of Pediatrics, Neuroscience and Psychiatry & Behavioral Sciences
Maia Szalavitz
Author of New York Times Bestseller: Unbroken Brain: A revolutionary New Way of Understanding Addiction
Stephen Shore, ED.D
Assistant professor of education Adelphi University; NY member of the iCare 4 Autism Advisory Committee
Gal Meiri, M.D.
Child Psychiatrist and Head of Preschool Psychiatric Unit at Soroka University Medical Center
Casara Jean Ferrett, M.S.
Doctoral student in the clinical Psychology PhD program with Health emphasis at Ferkauf Graduate School of Psychology
Chinazo Cunningham M.D., M
Associate Chief in division of general internal medicine. Prof. of Medicine at Montefiore Medical Center.
